| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apoptosis | 16 | 2019 | 1826 | 1.610 |
Why?
|
| Ischemia | 12 | 2024 | 359 | 1.560 |
Why?
|
| Myocytes, Cardiac | 10 | 2017 | 670 | 1.460 |
Why?
|
| Membrane Proteins | 8 | 2015 | 1589 | 1.130 |
Why?
|
| Cell Hypoxia | 10 | 2017 | 85 | 1.090 |
Why?
|
| Hindlimb | 6 | 2017 | 72 | 1.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 13 | 2024 | 324 | 1.050 |
Why?
|
| Neovascularization, Physiologic | 13 | 2021 | 196 | 1.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2012 | 83 | 0.980 |
Why?
|
| Chromogranins | 7 | 2023 | 30 | 0.920 |
Why?
|
| Mitochondrial Proteins | 3 | 2015 | 283 | 0.860 |
Why?
|
| Genetic Therapy | 6 | 2024 | 711 | 0.830 |
Why?
|
| Acidosis | 4 | 2012 | 97 | 0.820 |
Why?
|
| Animals | 70 | 2024 | 33676 | 0.810 |
Why?
|
| Biological Therapy | 1 | 2024 | 26 | 0.810 |
Why?
|
| Peripheral Arterial Disease | 3 | 2024 | 324 | 0.790 |
Why?
|
| Myocardial Infarction | 7 | 2017 | 997 | 0.770 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2007 | 598 | 0.740 |
Why?
|
| Neovascularization, Pathologic | 6 | 2022 | 227 | 0.740 |
Why?
|
| Myocardium | 8 | 2019 | 860 | 0.690 |
Why?
|
| Signal Transduction | 14 | 2022 | 4646 | 0.670 |
Why?
|
| Diabetic Retinopathy | 4 | 2024 | 75 | 0.650 |
Why?
|
| Choroidal Neovascularization | 4 | 2024 | 20 | 0.620 |
Why?
|
| Myocardial Ischemia | 4 | 2015 | 308 | 0.620 |
Why?
|
| Nephritis, Hereditary | 4 | 2023 | 21 | 0.590 |
Why?
|
| Femoral Artery | 2 | 2017 | 134 | 0.580 |
Why?
|
| Calcium | 4 | 2015 | 1009 | 0.580 |
Why?
|
| Hypoxia | 4 | 2004 | 247 | 0.570 |
Why?
|
| Regeneration | 3 | 2016 | 226 | 0.560 |
Why?
|
| Mice | 37 | 2024 | 18173 | 0.560 |
Why?
|
| Muscle, Skeletal | 5 | 2017 | 980 | 0.560 |
Why?
|
| Cells, Cultured | 14 | 2019 | 2885 | 0.540 |
Why?
|
| MicroRNAs | 5 | 2019 | 883 | 0.520 |
Why?
|
| Oxygen | 6 | 2022 | 549 | 0.510 |
Why?
|
| Retinopathy of Prematurity | 3 | 2022 | 65 | 0.500 |
Why?
|
| Rats | 13 | 2016 | 3372 | 0.500 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2007 | 130 | 0.480 |
Why?
|
| Oxidative Stress | 8 | 2019 | 790 | 0.470 |
Why?
|
| Calpain | 1 | 2015 | 42 | 0.450 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2015 | 47 | 0.450 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 3 | 2011 | 18 | 0.450 |
Why?
|
| Collagen Type IV | 4 | 2023 | 20 | 0.440 |
Why?
|
| Atherosclerosis | 5 | 2019 | 947 | 0.430 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2024 | 105 | 0.430 |
Why?
|
| Heart Diseases | 3 | 2004 | 499 | 0.430 |
Why?
|
| Enzyme Activation | 9 | 2015 | 576 | 0.430 |
Why?
|
| Bone Marrow Cells | 5 | 2016 | 243 | 0.420 |
Why?
|
| Cardiomegaly | 2 | 2012 | 118 | 0.400 |
Why?
|
| Apolipoproteins E | 4 | 2013 | 187 | 0.380 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 32 | 0.380 |
Why?
|
| Sirtuins | 1 | 2012 | 22 | 0.370 |
Why?
|
| Carbocyanines | 1 | 2012 | 9 | 0.370 |
Why?
|
| Mitochondria | 8 | 2019 | 768 | 0.370 |
Why?
|
| Heart Failure | 4 | 2022 | 2325 | 0.360 |
Why?
|
| Intra-Abdominal Fat | 1 | 2012 | 61 | 0.360 |
Why?
|
| Endodeoxyribonucleases | 1 | 2012 | 47 | 0.360 |
Why?
|
| Retinal Neovascularization | 3 | 2022 | 12 | 0.350 |
Why?
|
| Receptor, Insulin | 1 | 2011 | 65 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 16 | 2024 | 4694 | 0.350 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2019 | 171 | 0.340 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 335 | 0.340 |
Why?
|
| Disease Models, Animal | 16 | 2024 | 4642 | 0.330 |
Why?
|
| Cell Cycle | 2 | 2010 | 593 | 0.330 |
Why?
|
| Dietary Fats | 1 | 2012 | 276 | 0.330 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2011 | 169 | 0.320 |
Why?
|
| Physical Conditioning, Animal | 1 | 2011 | 84 | 0.310 |
Why?
|
| Osteopontin | 2 | 2021 | 54 | 0.310 |
Why?
|
| Phosphorylation | 7 | 2016 | 1570 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2007 | 165 | 0.300 |
Why?
|
| Hyperlipidemias | 2 | 2022 | 185 | 0.300 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 4 | 2024 | 95 | 0.290 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2017 | 42 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2019 | 61 | 0.280 |
Why?
|
| RNA-Binding Proteins | 2 | 2024 | 533 | 0.280 |
Why?
|
| Dyslipidemias | 1 | 2011 | 249 | 0.270 |
Why?
|
| Inflammation | 3 | 2023 | 1479 | 0.270 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2019 | 157 | 0.270 |
Why?
|
| Cell Movement | 5 | 2024 | 874 | 0.260 |
Why?
|
| Animals, Newborn | 5 | 2021 | 1022 | 0.250 |
Why?
|
| Dependovirus | 2 | 2024 | 159 | 0.250 |
Why?
|
| Autoantigens | 3 | 2022 | 97 | 0.250 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2021 | 365 | 0.250 |
Why?
|
| Protein Kinase C-alpha | 1 | 2007 | 20 | 0.250 |
Why?
|
| Retinal Vessels | 3 | 2023 | 48 | 0.250 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2017 | 19 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 4 | 2022 | 979 | 0.240 |
Why?
|
| Exosomes | 2 | 2017 | 60 | 0.240 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 56 | 0.240 |
Why?
|
| Transfection | 7 | 2013 | 961 | 0.240 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 258 | 0.240 |
Why?
|
| Hyperglycemia | 1 | 2008 | 233 | 0.230 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 2323 | 0.230 |
Why?
|
| Cell Proliferation | 8 | 2024 | 2463 | 0.230 |
Why?
|
| Genetic Vectors | 4 | 2024 | 892 | 0.230 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2016 | 83 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2011 | 409 | 0.220 |
Why?
|
| Drug Delivery Systems | 2 | 2022 | 218 | 0.220 |
Why?
|
| Exercise Therapy | 2 | 2021 | 172 | 0.220 |
Why?
|
| Proteins | 1 | 2010 | 1005 | 0.220 |
Why?
|
| Glycolysis | 2 | 2016 | 173 | 0.210 |
Why?
|
| Antibodies | 2 | 2021 | 316 | 0.210 |
Why?
|
| Humans | 39 | 2024 | 130204 | 0.210 |
Why?
|
| Laminin | 1 | 2024 | 65 | 0.210 |
Why?
|
| Aging | 2 | 2010 | 1238 | 0.210 |
Why?
|
| Diet | 1 | 2011 | 1103 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2012 | 1456 | 0.210 |
Why?
|
| Stem Cell Transplantation | 2 | 2003 | 224 | 0.210 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 30 | 0.210 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2019 | 224 | 0.200 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 34 | 0.200 |
Why?
|
| Mice, Transgenic | 4 | 2023 | 2331 | 0.200 |
Why?
|
| Drug Combinations | 1 | 2024 | 266 | 0.200 |
Why?
|
| Peptide Fragments | 2 | 2018 | 687 | 0.200 |
Why?
|
| Collagen | 1 | 2024 | 274 | 0.190 |
Why?
|
| China | 1 | 2024 | 277 | 0.190 |
Why?
|
| Macular Degeneration | 1 | 2024 | 85 | 0.190 |
Why?
|
| Gene Expression | 4 | 2015 | 1482 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2016 | 1109 | 0.180 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2022 | 18 | 0.180 |
Why?
|
| Biological Evolution | 1 | 2003 | 220 | 0.180 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2002 | 14 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2023 | 137 | 0.180 |
Why?
|
| Lower Extremity | 1 | 2024 | 184 | 0.180 |
Why?
|
| Endometrium | 2 | 2016 | 286 | 0.180 |
Why?
|
| Proteomics | 2 | 2022 | 615 | 0.180 |
Why?
|
| Heart | 2 | 2007 | 659 | 0.180 |
Why?
|
| Clinical Trials as Topic | 2 | 2024 | 1119 | 0.170 |
Why?
|
| Methionine Sulfoxide Reductases | 2 | 2011 | 4 | 0.170 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 662 | 0.170 |
Why?
|
| Mice, Knockout | 7 | 2022 | 3812 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 183 | 0.170 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 57 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2003 | 147 | 0.170 |
Why?
|
| Zinc Fingers | 1 | 2001 | 116 | 0.170 |
Why?
|
| Nicotine | 2 | 2013 | 115 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 57 | 0.170 |
Why?
|
| Aortic Aneurysm | 1 | 2023 | 222 | 0.160 |
Why?
|
| Blotting, Western | 3 | 2012 | 1014 | 0.160 |
Why?
|
| Hydrogen Peroxide | 4 | 2007 | 116 | 0.160 |
Why?
|
| Water-Electrolyte Balance | 1 | 2021 | 81 | 0.160 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2021 | 50 | 0.160 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 524 | 0.160 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 546 | 0.160 |
Why?
|
| Obesity | 1 | 2012 | 2401 | 0.160 |
Why?
|
| Oxidation-Reduction | 4 | 2011 | 435 | 0.160 |
Why?
|
| Coronary Disease | 2 | 2003 | 627 | 0.160 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 156 | 0.160 |
Why?
|
| Retinal Diseases | 1 | 2021 | 142 | 0.150 |
Why?
|
| Growth Hormone-Releasing Hormone | 2 | 2018 | 12 | 0.150 |
Why?
|
| Retina | 5 | 2023 | 423 | 0.150 |
Why?
|
| Receptors, CXCR4 | 2 | 2011 | 70 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 484 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 216 | 0.150 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2019 | 13 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2000 | 99 | 0.150 |
Why?
|
| Heart Failure, Diastolic | 1 | 2019 | 10 | 0.150 |
Why?
|
| Isoenzymes | 1 | 2000 | 212 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 344 | 0.150 |
Why?
|
| Corticosterone | 1 | 2019 | 49 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2003 | 757 | 0.150 |
Why?
|
| Adenoviridae | 2 | 2016 | 581 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2017 | 996 | 0.140 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 366 | 0.140 |
Why?
|
| Lipoproteins, LDL | 2 | 2022 | 119 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2003 | 804 | 0.140 |
Why?
|
| Cytokines | 2 | 2017 | 1333 | 0.140 |
Why?
|
| Kidney | 2 | 2023 | 1280 | 0.140 |
Why?
|
| Cell Line | 6 | 2015 | 2553 | 0.130 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2017 | 57 | 0.130 |
Why?
|
| Collateral Circulation | 1 | 2017 | 42 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2024 | 688 | 0.130 |
Why?
|
| Caspase 3 | 2 | 2015 | 121 | 0.130 |
Why?
|
| Gene Silencing | 2 | 2016 | 229 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 521 | 0.130 |
Why?
|
| Aortic Diseases | 1 | 2019 | 187 | 0.130 |
Why?
|
| Vascular Calcification | 1 | 2018 | 69 | 0.130 |
Why?
|
| Models, Biological | 4 | 2016 | 1375 | 0.130 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 1319 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 480 | 0.120 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2010 | 38 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2021 | 472 | 0.120 |
Why?
|
| Reperfusion | 1 | 2016 | 26 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 359 | 0.120 |
Why?
|
| Genomics | 1 | 2004 | 1617 | 0.120 |
Why?
|
| Oxidants | 3 | 2007 | 24 | 0.120 |
Why?
|
| Focal Adhesion Kinase 2 | 2 | 2007 | 7 | 0.120 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2016 | 72 | 0.120 |
Why?
|
| Stilbenes | 1 | 2016 | 34 | 0.120 |
Why?
|
| Receptors, Pituitary Hormone-Regulating Hormone | 3 | 2023 | 5 | 0.120 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 93 | 0.120 |
Why?
|
| Receptors, Neuropeptide | 3 | 2023 | 13 | 0.120 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 56 | 0.110 |
Why?
|
| GATA4 Transcription Factor | 1 | 2015 | 35 | 0.110 |
Why?
|
| PPAR gamma | 2 | 2013 | 88 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2003 | 2400 | 0.110 |
Why?
|
| Integrin beta1 | 1 | 2015 | 50 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 57 | 0.110 |
Why?
|
| Glucuronidase | 1 | 2015 | 32 | 0.110 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 127 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2012 | 686 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2016 | 138 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 295 | 0.110 |
Why?
|
| Acetylation | 1 | 2015 | 191 | 0.110 |
Why?
|
| Matrix Metalloproteinases | 2 | 2012 | 62 | 0.110 |
Why?
|
| Cell Death | 2 | 2007 | 226 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 992 | 0.110 |
Why?
|
| Blotting, Northern | 2 | 2004 | 234 | 0.100 |
Why?
|
| Alkaline Phosphatase | 2 | 2018 | 94 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 2 | 2017 | 589 | 0.100 |
Why?
|
| Tunica Intima | 2 | 2010 | 61 | 0.100 |
Why?
|
| CD36 Antigens | 1 | 2013 | 35 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 1212 | 0.100 |
Why?
|
| Stem Cells | 3 | 2013 | 704 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2013 | 610 | 0.090 |
Why?
|
| Male | 12 | 2023 | 64425 | 0.090 |
Why?
|
| Down-Regulation | 3 | 2021 | 646 | 0.090 |
Why?
|
| Cell Nucleus | 2 | 2012 | 558 | 0.090 |
Why?
|
| Mice, Inbred CBA | 1 | 2012 | 27 | 0.090 |
Why?
|
| Adenosine Triphosphate | 2 | 2011 | 265 | 0.090 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2012 | 2 | 0.090 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 521 | 0.090 |
Why?
|
| Protein Conformation | 2 | 2006 | 732 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2024 | 47 | 0.090 |
Why?
|
| Intravitreal Injections | 2 | 2022 | 35 | 0.090 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2022 | 59 | 0.090 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 83 | 0.090 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2022 | 53 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2012 | 223 | 0.090 |
Why?
|
| Kinetics | 2 | 2006 | 1087 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 2 | 2004 | 302 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 112 | 0.090 |
Why?
|
| Endothelial Cells | 3 | 2023 | 520 | 0.080 |
Why?
|
| Threonine | 1 | 2011 | 62 | 0.080 |
Why?
|
| Methionine | 1 | 2011 | 95 | 0.080 |
Why?
|
| Protein Transport | 1 | 2012 | 366 | 0.080 |
Why?
|
| Catalysis | 1 | 2011 | 136 | 0.080 |
Why?
|
| von Willebrand Factor | 1 | 2012 | 191 | 0.080 |
Why?
|
| Diet Therapy | 1 | 2011 | 40 | 0.080 |
Why?
|
| Neuroblastoma | 1 | 2016 | 547 | 0.080 |
Why?
|
| Ligands | 1 | 2011 | 479 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2010 | 12 | 0.080 |
Why?
|
| G2 Phase | 1 | 2010 | 39 | 0.080 |
Why?
|
| Nicotinic Agonists | 1 | 2010 | 33 | 0.080 |
Why?
|
| Argonaute Proteins | 1 | 2010 | 29 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2011 | 183 | 0.080 |
Why?
|
| Serine | 1 | 2011 | 161 | 0.080 |
Why?
|
| S Phase | 1 | 2010 | 76 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2010 | 106 | 0.080 |
Why?
|
| G1 Phase | 1 | 2010 | 68 | 0.080 |
Why?
|
| Cyclins | 1 | 2010 | 93 | 0.080 |
Why?
|
| Escherichia coli Proteins | 2 | 2003 | 314 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 369 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 242 | 0.080 |
Why?
|
| Coronary Restenosis | 1 | 2009 | 23 | 0.080 |
Why?
|
| Cell Survival | 3 | 2016 | 828 | 0.080 |
Why?
|
| Time Factors | 5 | 2017 | 6166 | 0.080 |
Why?
|
| Stroke Volume | 2 | 2022 | 536 | 0.080 |
Why?
|
| Weight Gain | 1 | 2012 | 385 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 322 | 0.080 |
Why?
|
| Mitosis | 1 | 2010 | 191 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2010 | 248 | 0.070 |
Why?
|
| Macrophages | 1 | 2013 | 660 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 1209 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 1604 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1592 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 287 | 0.070 |
Why?
|
| Eating | 1 | 2011 | 375 | 0.070 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2008 | 37 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 614 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2010 | 447 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2012 | 1112 | 0.070 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2007 | 13 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 476 | 0.070 |
Why?
|
| Apoptosomes | 1 | 2007 | 6 | 0.070 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2007 | 34 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2007 | 13 | 0.060 |
Why?
|
| Lipids | 1 | 2011 | 566 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 276 | 0.060 |
Why?
|
| Calcium Signaling | 2 | 2010 | 243 | 0.060 |
Why?
|
| Caspase 9 | 1 | 2007 | 76 | 0.060 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2006 | 8 | 0.060 |
Why?
|
| Foam Cells | 2 | 2019 | 21 | 0.060 |
Why?
|
| Mitochondria, Heart | 1 | 2007 | 58 | 0.060 |
Why?
|
| bcl-X Protein | 1 | 2006 | 32 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 61 | 0.060 |
Why?
|
| Dimerization | 1 | 2006 | 137 | 0.060 |
Why?
|
| Glucose | 1 | 2011 | 851 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2007 | 188 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 271 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 137 | 0.060 |
Why?
|
| Antioxidants | 2 | 2013 | 331 | 0.060 |
Why?
|
| Endostatins | 1 | 2005 | 10 | 0.060 |
Why?
|
| Aorta | 2 | 2019 | 522 | 0.060 |
Why?
|
| Female | 10 | 2023 | 70342 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2019 | 150 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2004 | 22 | 0.050 |
Why?
|
| Anisomycin | 1 | 2004 | 2 | 0.050 |
Why?
|
| Antimycin A | 1 | 2004 | 6 | 0.050 |
Why?
|
| Angiography | 1 | 2005 | 181 | 0.050 |
Why?
|
| Acute Disease | 1 | 2008 | 1153 | 0.050 |
Why?
|
| Protein Binding | 2 | 2015 | 1650 | 0.050 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2004 | 32 | 0.050 |
Why?
|
| Electron Transport | 1 | 2004 | 60 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2024 | 78 | 0.050 |
Why?
|
| Rabbits | 1 | 2005 | 573 | 0.050 |
Why?
|
| Sermorelin | 1 | 2023 | 3 | 0.050 |
Why?
|
| gamma-Globulins | 1 | 2023 | 2 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 65 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 18 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 559 | 0.050 |
Why?
|
| Melphalan | 1 | 2023 | 45 | 0.050 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2003 | 8 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 421 | 0.050 |
Why?
|
| Stents | 1 | 2009 | 784 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2003 | 58 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2003 | 203 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2007 | 523 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 101 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 219 | 0.050 |
Why?
|
| Adult | 1 | 2024 | 31035 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 23 | 0.050 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2003 | 116 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 54 | 0.050 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2002 | 38 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2003 | 91 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 89 | 0.050 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2002 | 37 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2002 | 42 | 0.050 |
Why?
|
| Indoles | 1 | 2003 | 200 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 467 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 198 | 0.040 |
Why?
|
| Cellular Senescence | 2 | 2016 | 216 | 0.040 |
Why?
|
| Necrosis | 1 | 2002 | 193 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 69 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2002 | 276 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2003 | 312 | 0.040 |
Why?
|
| Capillaries | 1 | 2022 | 63 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 1 | 2001 | 7 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 124 | 0.040 |
Why?
|
| Plasmids | 1 | 2002 | 444 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 2001 | 38 | 0.040 |
Why?
|
| COS Cells | 1 | 2001 | 253 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2022 | 177 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 3406 | 0.040 |
Why?
|
| Superoxides | 1 | 2001 | 125 | 0.040 |
Why?
|
| Cholesterol | 1 | 2024 | 537 | 0.040 |
Why?
|
| Phenotype | 2 | 2022 | 4454 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 96 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2001 | 105 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2021 | 117 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 2591 | 0.040 |
Why?
|
| Systole | 1 | 2021 | 195 | 0.040 |
Why?
|
| Cysteine | 1 | 2001 | 137 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2001 | 104 | 0.040 |
Why?
|
| Troponin T | 1 | 2022 | 255 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 744 | 0.040 |
Why?
|
| Diastole | 1 | 2021 | 181 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2002 | 450 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2000 | 33 | 0.040 |
Why?
|
| RNA Interference | 2 | 2013 | 491 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 565 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 37 | 0.040 |
Why?
|
| Biomarkers | 2 | 2021 | 3358 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 553 | 0.040 |
Why?
|
| Base Sequence | 2 | 2016 | 2730 | 0.040 |
Why?
|
| Ceramides | 1 | 2000 | 47 | 0.040 |
Why?
|
| Lymphokines | 1 | 2000 | 62 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2000 | 54 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2001 | 688 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 3 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 88 | 0.040 |
Why?
|
| Weight Loss | 1 | 2023 | 535 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 6062 | 0.040 |
Why?
|
| Extremities | 1 | 2000 | 73 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 882 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2019 | 18 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2000 | 79 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2000 | 99 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2021 | 446 | 0.040 |
Why?
|
| Binding Sites | 1 | 2001 | 1134 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 1205 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2018 | 9 | 0.030 |
Why?
|
| Prognosis | 1 | 2008 | 4847 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2018 | 13 | 0.030 |
Why?
|
| Forecasting | 1 | 2000 | 351 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2018 | 43 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2018 | 49 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 724 | 0.030 |
Why?
|
| Gangrene | 1 | 2017 | 26 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2017 | 83 | 0.030 |
Why?
|
| Culture Media | 1 | 2018 | 169 | 0.030 |
Why?
|
| Secretory Vesicles | 1 | 2017 | 20 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 269 | 0.030 |
Why?
|
| Ligation | 1 | 2017 | 134 | 0.030 |
Why?
|
| Genome, Human | 1 | 2004 | 1318 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 158 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 420 | 0.030 |
Why?
|
| Disease Progression | 1 | 2003 | 2190 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 191 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 679 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 470 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 60 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 186 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2018 | 182 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2548 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 401 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2016 | 68 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 416 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2016 | 23 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2016 | 41 | 0.030 |
Why?
|
| DNA | 1 | 2001 | 1397 | 0.030 |
Why?
|
| Endocytosis | 1 | 2016 | 121 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2016 | 97 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 2016 | 53 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1208 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1532 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2018 | 298 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2000 | 849 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 113 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 172 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 465 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 336 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 226 | 0.030 |
Why?
|
| Hypertension | 1 | 2002 | 1352 | 0.030 |
Why?
|
| Protein Kinase C-delta | 1 | 2013 | 12 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2016 | 498 | 0.020 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2013 | 53 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 888 | 0.020 |
Why?
|
| Risk Factors | 1 | 2008 | 10967 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 1930 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 112 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 585 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 226 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12824 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 784 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 283 | 0.020 |
Why?
|
| Neurons | 1 | 2021 | 1979 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 106 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 237 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 411 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2018 | 839 | 0.020 |
Why?
|
| Cytosol | 1 | 2011 | 135 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 765 | 0.020 |
Why?
|
| Pregnancy | 1 | 2003 | 7456 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 637 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 823 | 0.020 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2010 | 4 | 0.020 |
Why?
|
| Nicotinic Antagonists | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 706 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 413 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 99 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2010 | 52 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 88 | 0.020 |
Why?
|
| Iliac Artery | 1 | 2010 | 63 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 780 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 106 | 0.020 |
Why?
|
| Tomography, Optical | 1 | 2009 | 7 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2010 | 113 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2891 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2009 | 40 | 0.020 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2009 | 11 | 0.020 |
Why?
|
| Benzylamines | 1 | 2009 | 22 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2009 | 95 | 0.020 |
Why?
|
| Heterocyclic Compounds | 1 | 2009 | 17 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2009 | 27 | 0.020 |
Why?
|
| Catheterization | 1 | 2010 | 225 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 59 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8622 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 304 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3713 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 706 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 126 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1453 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 102 | 0.020 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2007 | 62 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 51 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 53 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 542 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 394 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 358 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3465 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2008 | 221 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1363 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 942 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1800 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 3147 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2005 | 1001 | 0.010 |
Why?
|